Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of David William Homan
Introduction
David William Homan, based in San Ramon, California, is an accomplished inventor with a remarkable focus on biochemistry and therapeutic advancements. His expertise in protein engineering has led to significant contributions in the field of enzyme therapy.
Latest Patents
Homan holds a patent for "Engineered Acid Alpha-Glucosidase Variants." This invention presents engineered acid alpha-glucosidase (GAA) polypeptides and related compositions. The engineered GAA polypeptides are designed to improve expression, stability at neutral pH, and activity in cell lysates, thus enhancing their applicability in therapeutic contexts.
Career Highlights
As part of his professional journey, David Homan works at Codexis, Inc., a leading company specializing in protein engineering and enzyme optimization. His work plays a crucial role in advancing the capabilities of therapeutic proteins, thereby impacting the treatment of various genetic disorders.
Collaborations
Throughout his career, Homan has collaborated with several talented professionals, including William Casey Hallows and Rachel Cathleen Botham. These partnerships have fostered a creative atmosphere for innovation and have contributed significantly to the success of their projects.
Conclusion
David William Homan exemplifies the spirit of innovation through his pioneering work in engineered enzymes. With his contributions, he continues to pave the way for advancements in enzyme therapies, showcasing the critical role of inventors in the scientific community.